FI880845A0 - bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi - Google Patents

bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi

Info

Publication number
FI880845A0
FI880845A0 FI880845A FI880845A FI880845A0 FI 880845 A0 FI880845 A0 FI 880845A0 FI 880845 A FI880845 A FI 880845A FI 880845 A FI880845 A FI 880845A FI 880845 A0 FI880845 A0 FI 880845A0
Authority
FI
Finland
Prior art keywords
mutein
dna
bfgf
producing
bacterium containing
Prior art date
Application number
FI880845A
Other languages
English (en)
Swedish (sv)
Other versions
FI96316B (fi
FI880845A (fi
FI96316C (fi
Inventor
Masaharu Senoo
Tsutomu Kurokawa
Koichi Igarashi
Reiko Sasada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI880845A0 publication Critical patent/FI880845A0/fi
Publication of FI880845A publication Critical patent/FI880845A/fi
Publication of FI96316B publication Critical patent/FI96316B/fi
Application granted granted Critical
Publication of FI96316C publication Critical patent/FI96316C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/503Fibroblast growth factor [FGF] basic FGF [bFGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FI880845A 1987-02-24 1988-02-23 bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi FI96316C (fi)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
JP4221887 1987-02-24
JP4221887 1987-02-24
JP4344487 1987-02-25
JP4344487 1987-02-25
JP8197787 1987-04-02
JP8197787 1987-04-02
JP14751187 1987-06-12
JP14751187 1987-06-12
JP20151087 1987-08-11
JP20151087 1987-08-11
JP29028387 1987-11-17
JP29028387 1987-11-17
JP1626088 1988-01-26
JP63016260A JP2526965B2 (ja) 1987-02-24 1988-01-26 ムテイン,dnaおよびその用途

Publications (4)

Publication Number Publication Date
FI880845A0 true FI880845A0 (fi) 1988-02-23
FI880845A FI880845A (fi) 1988-08-25
FI96316B FI96316B (fi) 1996-02-29
FI96316C FI96316C (fi) 1996-06-10

Family

ID=27563743

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880845A FI96316C (fi) 1987-02-24 1988-02-23 bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi

Country Status (14)

Country Link
EP (1) EP0281822B1 (fi)
JP (1) JP2526965B2 (fi)
KR (1) KR960013574B1 (fi)
CN (1) CN1031893C (fi)
AT (1) ATE108829T1 (fi)
AU (1) AU613564B2 (fi)
CS (1) CS407691A3 (fi)
DE (1) DE3850690T2 (fi)
DK (1) DK173269B1 (fi)
ES (1) ES2056842T3 (fi)
FI (1) FI96316C (fi)
IE (1) IE64299B1 (fi)
IL (1) IL85473A (fi)
NO (1) NO180305C (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852177A (en) * 1987-02-24 1998-12-22 Takeda Chemical Industries, Ltd. Basic fibroblast growth factor (bFGF) muteins
EP0364481A4 (en) * 1987-06-18 1992-01-22 Monash University Growth factors
AU611614B2 (en) * 1987-06-18 1991-06-13 Monash University Growth factors
GB8821795D0 (en) * 1988-09-16 1988-10-19 Erba Carlo Spa New derivatives of human/bovine basic fibroplast growth factor
US5352589A (en) * 1988-09-16 1994-10-04 Farmitalia Carlo Erba S.R.L. Deletion mutant of basic fibroblast growth factor and production thereof
US5120715A (en) * 1988-12-12 1992-06-09 Takeda Chemical Industries, Ltd. Method for purifying fibroblast growth factor protein
CA2015313A1 (en) * 1989-04-26 1990-10-26 Masaharu Senoo Glycosylated fgf and production thereof
US5464943A (en) * 1989-04-26 1995-11-07 Takeda Chemical Industries, Ltd. DNA encoding glycosylated FGF and production thereof
CA2020654A1 (en) * 1989-07-07 1991-01-08 Yohko Akiyama Stabilized fgf composition and production thereof
AU7162791A (en) * 1989-12-27 1991-07-24 Miroslav Radman Novel system for isolating and producing new genes, gene products and dna sequences
CA2069872A1 (en) 1989-12-28 1991-06-29 Yoshio Kozai Monoclonal antibody, hybridomas, their production and use
JPH047617A (ja) * 1990-04-26 1992-01-13 Canon Inc 電子機器
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5206354A (en) * 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
CA2056142A1 (en) 1990-11-27 1992-05-28 Hirotomo Masuya Pyridopyridazine compounds and their use
DE69211723T2 (de) * 1991-02-15 1996-10-31 Takeda Chemical Industries Ltd Mit einem Zellwachstumsfaktor bewirkte Anregung von Wachstum im Knocheninneren
EP0499990B1 (en) * 1991-02-19 1996-05-15 Takeda Chemical Industries, Ltd. Method for producing cysteine-free peptides
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
TW209174B (fi) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 bFGFムテインおよびその製造法
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
US6805865B1 (en) * 1993-05-27 2004-10-19 Entremed, Inc. Compositions and methods for treating cancer and hyperproliferative disorders
JPH07114789B2 (ja) * 1993-08-26 1995-12-13 工業技術院長 上肢動作補助機構
JPH09503661A (ja) * 1993-09-24 1997-04-15 アメリカン シアナミド カンパニー 繊維芽細胞成長因子の表面ループ構造アナログ
JP2562413B2 (ja) * 1993-11-04 1996-12-11 株式会社東京機械製作所 版胴における刷版装着装置
IT1269321B (it) * 1994-04-15 1997-03-26 Eniricerche Spa Mutanti stabili della d-n- -carbamilasi
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
AU2003242459B2 (en) 2002-06-18 2007-05-17 Eisai R&D Management Co., Ltd. Primary cultured adipocytes for gene therapy
WO2007109312A2 (en) 2006-03-20 2007-09-27 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
CN102690782A (zh) * 2012-06-14 2012-09-26 安徽农业大学 一种成纤维细胞培养液
KR101610861B1 (ko) * 2014-07-28 2016-04-11 (주)케어젠 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도
CN105924532A (zh) * 2016-06-08 2016-09-07 盘古基因生物工程(南京)股份有限公司 一种可溶性碱性成纤维细胞生长因子融合蛋白表达载体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
WO1989000198A1 (en) * 1987-07-07 1989-01-12 Biotechnology Research Associates, J.V. Recombinant fibroblast growth factors
ATE105868T1 (de) * 1985-09-12 1994-06-15 Scios Nova Inc Rekombinanter fibroblast-wachstumsfaktor.
JPH02504468A (ja) * 1987-11-24 1990-12-20 アムジエン・インコーポレーテツド 繊維芽細胞成長因子のアナログ

Also Published As

Publication number Publication date
DK92688D0 (da) 1988-02-23
IL85473A (en) 1997-03-18
CS407691A3 (en) 1992-06-17
KR880010130A (ko) 1988-10-07
FI96316B (fi) 1996-02-29
NO180305B (no) 1996-12-16
NO880719L (no) 1988-08-25
IE880482L (en) 1988-08-24
KR960013574B1 (en) 1996-10-09
AU1208588A (en) 1988-08-25
JPH02193A (ja) 1990-01-05
DK92688A (da) 1988-08-25
DE3850690D1 (de) 1994-08-25
DE3850690T2 (de) 1995-01-05
FI880845A (fi) 1988-08-25
EP0281822A2 (en) 1988-09-14
AU613564B2 (en) 1991-08-01
FI96316C (fi) 1996-06-10
ES2056842T3 (es) 1994-10-16
NO880719D0 (no) 1988-02-18
IE64299B1 (en) 1995-07-26
CN88100913A (zh) 1988-09-07
ATE108829T1 (de) 1994-08-15
EP0281822A3 (en) 1990-03-21
CN1031893C (zh) 1996-05-29
EP0281822B1 (en) 1994-07-20
DK173269B1 (da) 2000-05-29
JP2526965B2 (ja) 1996-08-21
NO180305C (no) 1997-03-26

Similar Documents

Publication Publication Date Title
FI880845A0 (fi) bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi
DK357386D0 (da) Saarhelende midler
IL96549A (en) Production of biologically active transforming growth factor type B-like protein or salts thereof
NO904378D0 (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
ES2057544T3 (es) Composiciones estabilizadas a base de fgf.
DE69530303D1 (de) Neue verwendung von prostaglandinen
FI882605A0 (fi) Menetelmä, jonka avulla voidaan valmistaa suuren spesifisen tilavuusaktiivisuuden omaavaa liuosta proteiinista, jolla on kudosplasminogeeniaktivaattori(t-PA)-aktiivisuutta
BG60324B2 (en) New somatotropines
DE69434997D1 (de) Menschliches Chondromodulin-I-Protein
CA2011008A1 (en) Egf variants and pharmaceutical use thereof
DE69019122T2 (de) Stabilisierung und Wartung der biologischen Aktivität des Nervenwachstumsfaktor unter Benützung von natürlichen Gangliosiden oder deren Derivaten.
DE69018357T2 (de) Mutein von HST-1 und seine Herstellung.
ATE106742T1 (de) Hemmung von hiv mittels transformationswachstumsfaktor beta.
ATE176279T1 (de) Chondromodulin-i-protein

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD.